Pinnacle Wealth Planning Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.1K Sell
487
-5
-1% -$341 ﹤0.01% 1460
2026
Q1
$31.8K Sell
492
-202
-29% -$14.2K ﹤0.01% 1455
2025
Q4
$46.7K Sell
694
-2,107
-75% -$142K ﹤0.01% 1241
2025
Q3
$205K Buy
+2,801
New +$186K 0.02% 448
2025
Q2
Sell
-3,588
Closed -$229K 468
2025
Q1
$229K Buy
+3,588
New +$208K 0.03% 326
2021
Q1
Sell
-881
Closed -$38K 1022
2020
Q4
$38K Buy
+881
New +$31.7K 0.01% 914

Other funds holding HALO

Pinnacle Wealth Planning Services's HALO Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its Halozyme (HALO) stake by 1% in Q2 2026, selling an estimated $341 and leaving 487 shares worth $38.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1460.

Pinnacle Wealth Planning Services first reported a position in HALO in Q4 2020 and has held it in 6 quarters since. The position peaked at $229K in Q1 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Pinnacle Wealth Planning Services held 487 shares of Halozyme worth $38.1K as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 5 Halozyme shares in Q2 2026, an estimated $341.
  • Halozyme made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1460 holding.
  • Pinnacle Wealth Planning Services first reported a position in Halozyme in Q4 2020 and has held it in 6 quarters since.
  • Pinnacle Wealth Planning Services's Halozyme position peaked at $229K in Q1 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.